Longeveron Inc.

Last updated September 27, 2026

Organization details

Legal name
Longeveron Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Miami
Headquarters state / province
Florida
Headquarters country
United States
Fiscal year end
December
Ticker symbol
LGVN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001721484
EIN
47-2174146

Board of directors

Chief executives

Mohamed Wa'el Ahmed Hashad · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 13, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 6 other boards. 6 are in the same sector.

Network of Longeveron Inc.'s board connections Akari Therapeutics plc Akari Therapeutics plc Bicycle Therapeutics plc Bicycle Therapeutics p... Clene Inc. Clene Inc. Processa Pharmaceuticals Inc. Processa Pharmaceutica... Seres Therapeutics Inc. Seres Therapeutics Inc... TriSalus Life Sciences Inc. TriSalus Life Sciences... Arjun Jj Desai Arjun Jj Desai Khoso Baluch Khoso Baluch Mohamed Wa'el Ahmed Hashad Mohamed Wa'el Ahmed... Richard N. Kender Richard N. Kender Longeveron Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 1, 2026 Agafonova Nataliya Officer (Chief Medical Officer) Shares withheld for tax −2,913 $2.59 $7,545
Oct 1, 2026 Blass Devin Officer (CTO & SVP of CMC) Shares withheld for tax −2,520 $2.59 $6,527
Oct 1, 2026 Jhaveri Nirav S. Officer (Chief Financial Officer) Shares withheld for tax −742 $2.59 $1,922
Oct 1, 2026 Lehr Paul T Officer (General Counsel, Secretary) Shares withheld for tax −2,253 $2.59 $5,835
Oct 1, 2026 Willard Stephen H Officer (Chief Executive Officer) Shares withheld for tax −1,987 $2.59 $5,146
Aug 19, 2026 Agafonova Nataliya Officer (Chief Medical Officer) Grant or award +286,000 — —
Aug 19, 2026 Deborah Ascheim Director Grant or award +36,000 — —
Aug 19, 2026 Blass Devin Officer (CTO & SVP of CMC) Grant or award +286,000 — —
Aug 19, 2026 Leah Rush Cann Director Grant or award +36,000 — —
Aug 19, 2026 Arjun Jj Desai Director Grant or award +36,000 — —
Aug 19, 2026 Roger Joseph Hajjar Director Grant or award +36,000 — —
Aug 19, 2026 Joshua Hare Director, Officer (Chief Scientific Officer), 10% owner Grant or award +286,000 — —
Aug 19, 2026 Lehr Paul T Officer (General Counsel, Secretary) Grant or award +286,000 — —
Aug 19, 2026 Ursula Ungaro Director Grant or award +36,000 — —
Aug 19, 2026 George A. Paletta Jr. Director Grant or award +36,000 — —

Organizations in the same sector, closest in location and size first.

Questions about Longeveron Inc.

Who is the CEO of Longeveron Inc.?

Mohamed Wa'el Ahmed Hashad is Longeveron Inc.'s Chief Executive Officer.

How many directors are on Longeveron Inc.'s board?

Longeveron Inc.'s board has 16 directors: Arjun Jj Desai, Cathy Ross, Deborah Ascheim, Douglas W. Losordo, George A. Paletta Jr., Jeffrey Pfeffer, Joshua Hare, Khoso Baluch, Leah Rush Cann, Mohamed Wa'el Ahmed Hashad and 6 others.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="longeveron-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.